Stereotaxis (STXS) Share-based Compensation (2010 - 2026)
Stereotaxis' (STXS) quarterly Share-based Compensation came in at $2.1 million in Q1 2026, down 16.77% year-on-year from $2.5 million in Q1 2025, and down 13.77% on a QoQ basis from $2.4 million in Q4 2025.
Stereotaxis (STXS) Share-based Compensation (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Share-based Compensation data on file, last reported at $2.1 million in Q1 2026.
- On a quarterly basis, Share-based Compensation fell 16.77% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 7.71% decrease from a year earlier, with the FY2025 full-year figure at $9.9 million, down 66.94% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.1 million, down from $2.4 million in the prior quarter.
- Over the last five years, Share-based Compensation for STXS reached as high as $49.5 million in Q1 2022 and fell as low as -$496000.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $17.0 million across 5 years, with a median of $2.6 million in 2023.
- Across the five-year window, Share-based Compensation surged 3510.5% in 2022 and slumped 118.82% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $2.7 million in 2022, then dropped by 1.27% to $2.6 million in 2023, then tumbled by 118.82% to -$496000.0 in 2024, then jumped by 593.35% to $2.4 million in 2025, then slipped by 13.77% to $2.1 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $2.1 million in Q1 2026, $2.4 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | -496,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Sep 30, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Dec 31, 2023 | 2.64 Mn |